Expected Admission Date for Consideration Shares

OKYO Pharma Limited
(Incorporated and registered in Guernsey with registered number 65220)

Expected Admission Date for Consideration Shares

OKYO Pharma Limited (LSE:OKYO) (the “Company“) today announces that in connection with its announcement on 24 October 2018 (the “24 October Announcement”), regarding its agreement to allot 512,866 ordinary shares of no par value in the capital of the Company (the “Consideration Shares”) to Dr. Alan Kopin and Dr. Benjamin Harwood in lieu of a cash payment pursuant to the terms of the Amended Collaboration Agreement (as defined in the 24 October Announcement), that such Consideration Shares are expected to be admitted to listing on the standard segment of the Official List maintained by the Financial Conduct Authority under Chapter 14 of the Listing Rules and to trading on the main market for listed securities of London Stock Exchange plc on 5 November 2018.

End

Enquiries:

For further information, please visit the Company’s website at www.okyopharma.com.